Friday, May 1, 2026

Neurophet AQUA AD Plus: Revolutionizing Alzheimer’s Diagnosis with AI at AD/PD 2026

Neurophet showcased its AI solutions for Alzheimer's at AD/PD 2026, aiming to foster collaborations in treatment development.

2026 Military Power Rankings: South Korea Rises to 5th Place—What Does This Mean?

South Korea ranks fifth in military strength globally, while North Korea climbs to 31st, according to Global Firepower's latest report.

The “Next AI Phone” Takes Center Stage in San Francisco

Samsung unveils Galaxy S26 series with advanced AI, Exynos 2600 chip, and new privacy features, set for launch on February 25.

Tag: Amivantamab

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Top News

- Our Sponsors Ad -

Follow us